Lv66
1790 积分 2024-02-08 加入
CD70 as a therapeutic target in human malignancies
2天前
已完结
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
21天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
21天前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
27天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
28天前
已完结
CAR-T therapy for ovarian cancer: Recent advances and future directions
1个月前
已完结
New developments in the diagnosis of primary immune thrombocytopenia
2个月前
已完结
Clinical significance of antinuclear antibodies in primary immune thrombocytopenia
2个月前
已完结
Immune thrombocytopenia in patients with systemic lupus erythematosus
2个月前
已完结
Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus
2个月前
已完结
皖公网安备34019202002308
